相关实验视频

Updated: Jan 16, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

针对勃起功能障碍的微能疗法的治疗效果:基于随机对照试验的系统审查和元分析

Hao Li¹, Wenchao Xu¹, Tao Wang¹

¹Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

The world journal of men's health

|October 5, 2025

概括

微能疗法 (MET) 有效地改善勃起功能障碍 (ED),长达一年,特别是血管性ED. 最佳的方案包括每周两次会议,并将MET与其他疗法结合起来可以提高结果.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
再生医学是一种再生医学.
医疗技术医疗技术医学技术

背景情况:

勃起功能障碍 (ED) 是一种普遍的疾病,影响着数百万男性.
微能疗法 (MET) 是一种新兴的治疗方案,用于ED.
MET包括低强度的体外冲击波疗法,低强度的脉冲超声波和电磁场.

研究的目的:

评估微能疗法 (MET) 对勃起功能障碍 (ED) 的治疗疗效.
在管理ED时确定MET的最佳治疗参数.
为了总结当前关于ED的MET的文献.

主要方法:

在PubMed,Web of Science和Embase进行了系统的文献搜索.
包括32项随机对照试验,涉及1986名ED患者.
使用国际勃起功能指数和勃起硬度得分评估治疗效果,对各种参数进行子组分析.

主要成果:

与对照组相比,MET在治疗后1,3,6和12个月显著改善了勃起功能.
每周两次治疗比每周一次治疗更有效 (p<0.05).
血管性ED显示出比神经性ED更好的反应 (p<0.05);组合治疗增强了疗效 (p<0.05).

结论:

微能疗法 (MET) 对各种ED类型有效,有效性持续长达一年.
最佳的治疗方案包括每周两次,不超过4周的治疗.
将MET与其他疗法相结合,在ED治疗中产生协同效应.

关键词:

电磁场是一种电磁场.勃起功能障碍是因为勃起功能障碍.身体外冲击波疗法身体外冲击波疗法固酶5抑制剂的使用超声波是一种超声波.

更多相关视频

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...